The Patent Finder

Blaze Bioscience, Inc.

4 patents currently held · Updated Nov 17, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 9, 2027
    The maintenance fee for Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereof (US 11,866,466) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 4 of 4

PatentTitleStatus Expires Confidence
US 12,048,750Tissue-homing peptide conjugates and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,559,580Tissue-homing peptide conjugates and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,048,732Methods of treating breast cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,866,466Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 4: 2 patents in force now held by others · 2 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 6 abandoned · 11 no status recorded

Showing 1 to 10 of 19, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/618,998Mar 27, 2024No status recorded
18/518,088Nov 22, 2023No status recorded
18/177,642Mar 2, 2023Abandoned
18/160,954Jan 27, 2023No status recorded
18/683,490Transferrin Receptor Targeting Peptide Oligonucleotide Complexes and Methods of Use ThereofAug 16, 2022Pending
18/037,926PD-L1 Binding Peptides and Peptide Complexes and Methods of Use ThereofNov 29, 2021Abandoned
18/037,923Compositions and Methods for Selective Depletion of Target MoleculesNov 29, 2021Pending
18/012,621Systems and Methods for Simultaneous Near-Infrared Light and Visible Light ImagingJun 25, 2021Abandoned
17/230,353Apr 14, 2021No status recorded
17/764,132Oct 1, 2020No status recorded
10 of 19 applications shown.
Pro members see all 19 published applications.
Pro members: see all 19 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited